ArticleComplex psychiatry
Development of the Comprehensive Addiction Risk Evaluation System: Initial Participant Response to an Online Personalized Feedback Program Integrating Genomic, Behavioral, and Environmental Risk Information.
Article in Complex psychiatry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Are polygenic scores for psychiatric and substance use outcomes "ready" for clinical application? Current state and next steps.Psychiatric genetics · 2026Review
- Substance use disorders exhibit unique and disorder specific genetic associations with externalizing and internalizing psychopathology.medRxiv : the preprint server for health sciences · 2026Article
- The power of parenting: mitigating conduct problems among adolescents carrying genetic risk.Frontiers in child and adolescent psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: We have made tremendous advances in understanding the etiology of substance use disorders (SUDs). Despite these advances, screening for SUDs has remained largely unchanged. In this paper, we describe an effort to build a program that integrates advances across genomics, developmental psychology, and epidemiology to provide individuals with personalized information about their addiction risk profile. Methods: The program was developed based on foundational work from a NIDA-funded project that conducted multivariate analyses of externalizing phenotypes to advance gene identification for SUDs and then characterized how polygenic scores (PGS) and early life behavioral and environmental factors predicted SUDs in diverse longitudinal samples. Based on this work, we created PGS and a behavioral and environmental risk index to generate personalized risk profiles. We carefully considered ethical concerns when developing the program. Results: We created a user-friendly, self-directed online platform that provides personalized risk information, including overall risk for developing an SUD based on an individual's combination of genetic, behavioral, and environmental risk, and specific information about genetic risk, based on PGS, and behavioral/environmental risk. Data from the first 188 participants enrolled in an ongoing study to evaluate the platform indicate high satisfaction and low distress at receiving genetic information. Conclusion: Provision of personalized feedback about addiction risk factors, including genetic information along with behavioral and environmental feedback, may be a viable way to promote earlier screening and intervention with the goal of preventing substance use problems before they start.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.